Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphoma
Kitsada Wudhikarn, Suporn Chuncharunee(Mahidol University), Pannee Praditsuktavorn(Chulabhorn Hospital), Nisa Makruasri(Srinakharinwirot University), Lalita Norasetthada(Chiang Mai University), Somchai Wongkhantee(Khon Kaen University), Nonglak Kanitsap(Thammasat University), Tawatchai Suwanban(Rajavithi Hospital), Pimjai Niparuck(Mahidol University), Weerasak Nawarawong(Chiang Mai University), Udomsak Bunworasate(Chulalongkorn University), Kanchana Chansung(Khon Kaen University), Arnuparp Lekhakula(Prince of Songkla University), Tontanai Numbenjapon(Phramongkutklao Hospital), Supachai Ekwattanakit(Siriraj Hospital), Tanin Intragumtornchai(Chulalongkorn University), Jakrawadee Julamanee(Prince of Songkla University), Peerapon Wong(Naresuan University), Chittima Sirijerachai(Khon Kaen University), Kannadit Prayongratana(Phramongkutklao Hospital), Archrob Khuhapinant(Siriraj Hospital)
Cited by 13
Related Papers
Clinical Classification, Screening and Diagnosis for Thalassemia
|Hematology/Oncology Clinics of North America|2018|262
High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma – Results of a comprehensive meta-analysis
|Cancer Treatment Reviews|2007|86